Get started Log in

MAB — Mabion SA Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapMomentum Trap

Market Cap
PLN124.93m
Enterprise Value
PLN143.63m
Revenue
PLN15.76m

Poland's Mabion surges on commercial production deal with Novavax
08/10/2021 08:23
Brief: Mabion Signs $372 Commercial Scale Production Deal With Novavax
08/10/2021 07:41
Brief: Mabion Q2 Net Loss Narrows To 2.5 Mln Zlotys
16/09/2021 06:41
Brief: Mabion Gets Extension Of Permit For Carrying Out Activity In SEZ In Lodz
10/08/2021 12:50
Brief: Mabion Has Adopted Joint Growth Strategy To Register Mabioncd20 On Both American And European Market
02/08/2021 07:27
Brief: Mabion Gets Second Statement Of Work From Novavax
24/06/2021 08:09
Poland - Factors to Watch June 16
16/06/2021 07:15
Focus: Big pharma and private equity seek healthy returns in Europe's east
20/05/2021 07:00
Brief: Mabion Appoints Krzysztof Kaczmarczyk As CEO
14/05/2021 06:33
Poland - Factors to Watch May 5
05/05/2021 07:00
Brief: Poland's Mabion FY 2020 Net Loss Narrows To 55.8 Mln Zlotys
04/05/2021 07:21
Brief: Mabion Signs Annex To Deal With Mylan Ireland Regarding MabionCD20
29/04/2021 14:48
Poland's Mabion aims to produce Novavax vaccine for Europe from Q3
01/04/2021 13:58
Poland - Factors to Watch March 15
15/03/2021 07:26
Brief: Mabion Sets Issue Price Of U Series Shares At 55 Zlotys/Shr
10/03/2021 06:12
Mabion: Continues U.S. vaccine deal-induced rally
04/03/2021 09:29
Brief: Mabion Starts ABB Process Of Up To 2.4 Mln U Series Shares
04/03/2021 07:45
Poland strikes deal to produce Novavax COVID-19 vaccine (updated)
03/03/2021 11:35
Shares in Poland's Mabion surge on Novavax vaccine programme deal
03/03/2021 09:32
Mabion: Surges on COVID-19 vaccine deal with Novavax
03/03/2021 08:35